Abdi K, Reed M L, Mentzer S J, Herrmann S H
Department of Pathology, Harvard Medical School, Boston, MA 02115.
J Immunol. 1989 May 1;142(9):2971-80.
Antibody reactive with the CD3 complex on the surface of T lymphocytes can either: inhibit CTL lysis of target cells expressing Ag; or redirect CTL to lyse target cells expressing FcR in the absence of Ag expression. To investigate these phenomena we examined the effect of anti-CD3 mAb on two indicators of CTL activation, the release of esterase and target cell lysis. Esterase release by long term allo-reactive human CTL in response to target cells (JY or HLA transfected K562 cells) was found to be Ag specific and correlate with target cell lysis. Addition of anti-CD3 to either JY targets or K562 cells expressing FcR resulted in a high level of esterase release. Triggering of esterase release was found with both soluble intact and Fab fragment of anti-CD3 in the absence of cells expressing measurable FcR. This apparent FcR-independent triggering of esterase release occurred at 37 degrees C but not at 24 degrees C. In contrast esterase activity was released from CTL at both 24 and 37 degrees C in response to intact target cells, JY or K562 cells plus intact anti-CD3 mAb. Addition of anti-CD3 mAb, at a level capable of blocking target cell lysis by greater than 50%, resulted in an initial velocity of esterase release almost twice that found in response to JY target cells. With a low level of anti-CD3 mAb, able to block JY lysis by approximately 10%, the initial rate of esterase release was much slower than that found in response to target cells. In contrast when FcR+ cells, K562, were added along with a low level of anti-CD3 the initial velocity of esterase release was about twofold more than the velocity of esterase release triggered by soluble anti-CD3 alone. These results indicate that soluble antibody can trigger long term active CTL and the velocity of this triggering correlates with anti-CD3-mediated inhibition as well as redirected lysis.
与T淋巴细胞表面CD3复合物发生反应的抗体可以:抑制表达抗原的靶细胞的细胞毒性T淋巴细胞(CTL)裂解;或者在无抗原表达的情况下,使CTL重新定向裂解表达Fc受体的靶细胞。为了研究这些现象,我们检测了抗CD3单克隆抗体对CTL激活的两个指标的影响,即酯酶释放和靶细胞裂解。发现长期同种反应性人CTL对靶细胞(JY或HLA转染的K562细胞)的酯酶释放具有抗原特异性,且与靶细胞裂解相关。将抗CD3添加到JY靶细胞或表达Fc受体的K562细胞中,会导致高水平的酯酶释放。在不存在表达可测量Fc受体的细胞的情况下,可溶性完整抗CD3及其Fab片段均可触发酯酶释放。这种明显的不依赖Fc受体的酯酶释放触发在37℃时发生,而在24℃时不发生。相比之下,在24℃和37℃时,完整靶细胞JY或K562细胞加完整抗CD3单克隆抗体均可使CTL释放酯酶活性。添加能阻断靶细胞裂解超过50%的抗CD3单克隆抗体,会使酯酶释放的初始速度几乎是对JY靶细胞反应时的两倍。使用能阻断JY裂解约10%的低水平抗CD3单克隆抗体时,酯酶释放的初始速率比靶细胞反应时慢得多。相比之下,当加入低水平抗CD3的同时添加FcR+细胞K562时,酯酶释放的初始速度比单独可溶性抗CD3触发的酯酶释放速度约快两倍。这些结果表明,可溶性抗体可触发长期活化的CTL,且这种触发速度与抗CD3介导的抑制以及重新定向裂解相关。